Talat Imran
2022
In 2022, Talat Imran earned a total compensation of $4.3M as Chief Executive Officer at Rani Therapeutics Holdings, a 63% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $312,000 |
|---|---|
| Option Awards | $2,340,204 |
| Salary | $515,000 |
| Stock Awards | $1,143,986 |
| Total | $4,311,190 |
Imran received $2.3M in option awards, accounting for 54% of the total pay in 2022.
Imran also received $312K in non-equity incentive plan, $515K in salary and $1.1M in stock awards.
Rankings
In 2022, Talat Imran's compensation ranked 786th out of 5,760 executives tracked by ExecPay. In other words, Imran earned more than 86.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 786 out of 5,760 | 86th |
Division Manufacturing | 357 out of 3,136 | 89th |
Major group Chemicals And Allied Products | 120 out of 1,422 | 92nd |
Industry group Drugs | 107 out of 1,323 | 92nd |
Industry Pharmaceutical Preparations | 78 out of 969 | 92nd |
Source: SEC filing on April 11, 2023.
Imran's colleagues
We found two more compensation records of executives who worked with Talat Imran at Rani Therapeutics Holdings in 2022.